Skip to main content

Capers Dorothy Trefon's Form 4 filing

Xylem Inc. (XYL) · filed Mar 6, 2025

Accession no.
0001562180-25-002143
Filed
Mar 6, 2025
Trade date
Mar 4-5, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.53M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Capers Dorothy TrefonCIK 0001905353Officer (SVP & General Counsel)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 4, 2025Common StockMOption exerciseAcquired+7,868$86.76+$682,627.6815,883Direct
Mar 4, 2025Common StockMOption exerciseAcquired+4,158$101.09+$420,332.2220,041Direct
Mar 4, 2025Common StockSSaleDisposed−12,026$127.26F1−$1,530,428.768,015Direct
Mar 5, 2025Common StockAGrant or awardAcquired+1,398$129.67+$181,278.669,413Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 4, 2025Common StockMOption exerciseDisposed−4,158$0.00$02,079Direct
Mar 4, 2025Common StockMOption exerciseDisposed−7,868$0.00$00Direct
Mar 5, 2025Common StockAGrant or awardAcquired+4,905$129.67+$636,031.354,905Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 12,026 Shares were executed at a range of prices from $125.25 to $125.35. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)